Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness
International Journal of Environmental Research and Public Health · 2023
DOI: 10.3390/ijerph20032404 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Ahmad Yaman Abdin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bioorganic Chemistry, School of Pharmacy, Saarland University, D-66123 Saarbrucken, Germany. Hauptthemen laut MEDLINE: Emergencies, Pandemics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saarland University and the Landesforschungsförderungsprogramm of the State of Saarland, European Research Consortium for Informatics and Mathematics.
Abstract (Originalsprache)
Public heath emergencies such as the outbreak of novel infectious diseases represent a major challenge for drug regulatory bodies, practitioners, and scientific communities. In such critical situations drug regulators and public health practitioners base their decisions on evidence generated and synthesised by scientists. The urgency and novelty of the situation create high levels of uncertainty concerning the safety and effectiveness of drugs. One key tool to mitigate such emergencies is pandemic preparedness. There seems to be, however, a lack of scholarly work on methodology for assessments of new or existing drugs during a pandemic. Issues related to risk attitudes, evidence production and evidence synthesis for drug approval require closer attention. This manuscript, therefore, engages in a conceptual analysis of relevant issues of drug assessment during a pandemic. To this end, we rely in our analysis on recent discussions in the philosophy of science and the philosophy of medicine. Important unanswered foundational questions are identified and possible ways to answer them are considered. Similar problems often have similar solutions, hence studying similar situations can provide important clues. We consider drug assessments of orphan drugs and drug assessments during endemics as similar to drug assessment during a pandemic. Furthermore, other scientific fields which cannot carry out controlled experiments may guide the methodology to draw defeasible causal inferences from imperfect data. Future contributions on methodologies for addressing the issues raised here will indeed have great potential to improve pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Bioorganic Chemistry, School of Pharmacy, Saarland University, D-66123 Saarbrucken, Germany.
- Department of Communication and Economics, University of Modena and Reggio Emilia, 42121 Reggio Emilia, Italy.
- VTT Technical Research Centre of Finland Ltd., 70210 Kuopio, Finland.
- Department of Philosophy "Piero Martinetti", University of Milan, 20122 Milan, Italy.
ORCID-Profile: Ahmad Yaman Abdin
Förderung
- Saarland University and the Landesforschungsförderungsprogramm of the State of Saarland
- European Research Consortium for Informatics and Mathematics
Zitieren
APA
Abdin, A. Y., De Pretis, F., & Landes, J. (2023). Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20032404
Vancouver
Abdin AY, De Pretis F, Landes J. Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20032404
BibTeX
@article{Abdin2023,
author = {Abdin, Ahmad Yaman and De Pretis, Francesco and Landes, Jürgen},
title = {Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
doi = {10.3390/ijerph20032404}
}
EUVIMED